Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2745344012 | Naptumomab (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 2772692016 | Naptumomab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3650504010 | Product containing naptumomab (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3650505011 | Product containing naptumomab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3668703017 | Naptumomab product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3715876015 | Naptumomab-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Naptumomab-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Naptumomab-containing product | Is a | Monoclonal antibody antineoplastic agent | true | Inferred relationship | Some | ||
| Naptumomab-containing product | Is a | Antineoplastic agent | false | Inferred relationship | Some | ||
| Naptumomab-containing product | Is a | Monoclonal antibody-containing product | false | Inferred relationship | Some | ||
| Naptumomab-containing product | Has active ingredient | Naptumomab | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Naptumomab only product | Is a | True | Naptumomab-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR